2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
PepGen Announces First Participant Dosed in a Phase 1 Clinical Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
- Initiation of Phase 1 Study Marks PepGen’s Transition to a Clinical Stage Company - - This Phase 1 Healthy...
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Collegium Appoints Neil McFarlane to its Board of Directors
STOUGHTON, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today...
New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure
Study Presented at the 71st Annual American College of Cardiology Meeting Oak Ridge, TN, April 06, 2022 (GLOBE NEWSWIRE) --...
Morphic Therapeutic Expands Leadership with Key Appointments in Clinical and Corporate Development
Dr. Brihad Abhyankar named Vice President of Clinical Development, deeply experienced GI drug development leaderAaron Pelta promoted to Senior Vice...
Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personalized Cancer Immunotherapies
Tuesday, April 12th @ 12:30 pm ETCOPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”...
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company...
TG Therapeutics Announces Oral Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the American Academy of Neurology Annual Meeting
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data from the ULTIMATE I &...
CloudMD Announces CEO Succession
Dr. Essam Hamza stepping down as CEO and President, Karen Adams appointed as Interim CEOVANCOUVER, British Columbia, April 06, 2022...
Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference
BOSTON, April 06, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for...
Government inaction on workplace protections undermining pandemic recovery and abandoning workers in sixth wave, according to health experts
TORONTO, April 06, 2022 (GLOBE NEWSWIRE) -- As Ontario faces a sixth wave of COVID infections and restrictions are being...
OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Extended existing master services agreement with Sandoz, to develop digital platform for development and life cycle management of antibiotics, to...
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs...
CorVel Releases the New Integrated Claims Risk Score for Workers’ Compensation Claims, Leveraging Artificial Intelligence and Predictive Analytics
The new functionality in CareMC Edge® assesses multiple factors to determine a claim risk score, helping claims professionals proactively address potential...
The Joint Corp. Acquires Northern California Regional Developer Territory
Expected to increase margin contribution and support corporate clinic growth opportunitySCOTTSDALE, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- The Joint...
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
Teladoc Health to Announce First Quarter 2022 Financial Results
PURCHASE, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,...
Tonix Pharmaceuticals Announces IND Clearance for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC)
Phase 2 Clinical Trial of TNX-102 SL for the Treatment of Long COVID Expected to Start Second Quarter 2022 Long...
Red Light Holland CTIO, Sarah Hashkes, Publishes Microdosing Article and will be Participating in an Online Webinar by Harvard’s Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School
Red Light Holland's Sarah Hashkes' article titled "A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation" is...
Awakn Successfully Completes Phase One of Its Drug Discovery Program
Two Chemical Series Identified to Facilitate Lead Optimisation ActivitiesToronto, Ontario--(Newsfile Corp. - April 6, 2022) - Awakn Life Sciences Corp....